Navigation Links
Sweeping view of prostate cancer genome yields deep insights
Date:2/9/2011

NEW YORK, CAMBRIDGE, Mass., AND BOSTON (Feb. 9, 2011) -- For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth. The work was led by researchers from Weill Cornell Medical College, the Broad Institute, and the Dana-Farber Cancer Institute and appears in the Feb. 10th issue of the journal Nature.

Unlike other sequencing methods that target specific sections of the genome, whole genome sequencing enables researchers to look across the entire DNA landscape of a tumor, making it possible to discern global changes and patterns. Senior authors Drs. Levi Garraway and Mark Rubin and their colleagues used this strategy to view the complete genomes of seven prostate tumors and compare them to normal tissue samples to find regions of abnormality.

"Whole genome sequencing gives us fascinating new insights into a category of alterations that may be especially important in prostate cancer," says Dr. Garraway, a senior associate member of the Broad Institute and a medical oncologist and assistant professor at the Dana-Farber and Harvard Medical School.

Prostate cancer is the second most lethal cancer in American men, responsible for more than 30,000 deaths and more than 200,000 new cases each year. A major goal of prostate cancer research is to identify potential drug targets as well as genetic characteristics within tumors that could distinguish indolent and aggressive forms of the disease, and ultimately improve diagnostics and treatment.

Dr. Rubin, the Homer T. Hirst Professor of Oncology in Pathology and vice chair for experimental pat
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Oil spill reshapes sweeping new study of oyster reefs -- Virginia to Florida
2. Uncovering the genetics of prostate cancer
3. MicroRNA suppresses prostate cancer stem cells and metastasis
4. Researchers learn why PSA levels reflect prostate cancer progression
5. An earlier start on diagnosing breast, prostate cancers
6. Soy may stop prostate cancer spread
7. UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer
8. Prostate cancers multiple personalities revealed
9. Vitamin E in front line of prostate cancer fight
10. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
11. Gene variations that alter key enzyme linked to prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015   Codonics ... safety systems and image documentation solutions and ... comprehensive, technologically-advanced automation solutions, is pleased to ... The Codonics® Safe Label System® (SLS), an ... conjunction with the Omnicell Anesthesia Workstation, helps ...
(Date:5/26/2015)... , May 26, 2015 ... announced the addition of the "Saudi Arabia ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... Arabia is projected to grow at ... high growth is attributed to the surging demand ...
(Date:5/25/2015)... May 25, 2015  Australia,s market for wearable technologies ... 2014 saw the advent of several trials and prototypes. ... 2015 is expected to ignite interest in wearables as ... Australia . This in turn will spur ... drive new partnerships amongst vendors and distributors. ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... has published a paper today that is the most ... temperatures are having on the worlds coral reefs. ... Change and Ocean Acidification, co-authored by seventeen marine scientists ... will not survive the drastic increases in global temperatures ...
... Mass. -- A pioneering study of wild chimpanzees has ... experience menopause, rebutting previous studies of captive individuals which ... 35 to 40 years of age. Together with ... -- described this week in the journal Current Biology ...
... the Open Access publisher for Physics, Mathematics and ... CERN and DESY high-energy physics laboratories. Under ... charges for all research published by their investigators ... A. PMC Physics A is edited by ...
Cached Biology News:Immediate action needed to save corals from climate change 2Immediate action needed to save corals from climate change 3Wild chimpanzees appear not to regularly experience menopause 2Top physics laboratories sign up to open access with PhysMath Central 2
(Date:5/27/2015)... Mass. , May 27, 2015  RXi ... company focused on discovering and developing innovative therapies ... today provided an update on the status of the ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... were 3,085 and 21 shares of Series A ...
(Date:5/26/2015)... Regenestem Network has announced ... in Buenos Aires, Argentina. The clinic will be lead ... Pastrana has assembled a multidisciplinary team of medical professionals ... state-of-the-art Puerto Madero office. , The new Regenestem ... IV clinical studies in cellular therapies, and establish Regenestem ...
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
(Date:5/26/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), ... modernized traditional Chinese medicine (mTCM), branded generics and active ... of Shareholders for fiscal year ended June 30, 2014 ... office located in Chengdu, China ... in Chengdu, China ) on May ...
Breaking Biology Technology:RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
... , NAGOYA, Japan , Jan. ... with the collaboration of Osaka University, has successfully ... and H3N2) type influenza virus by utilizing blood samples from ... Kazuyoshi Ikuta , Ph. D., at the Department of Virology, ...
... , TUALATIN, Ore. , ... Board: WYNX), a platform company dedicated to the acquisition, ... that it has reached an agreement with British-based Ingenion ... generation Gas Quality Inferential Measurement Device (GasPT2). , The ...
... LEIDEN, The Netherlands , January ... collaborations that are extremely,valuable for pharmaceutical research in the ... of the Top Institute, which was published today. In,the report, ... that,TI Pharma is well on its way to achieving the ...
Cached Biology Technology:Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner 2Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 2Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 4Veerman Committee Argues for Continuation of TI Pharma 2
... calibrating single-channel and multi-channel pipettes. ,Thanks to ... case, the MCP1-S is ideal for calibrating ... at the users premises. The unit is ... channels are tested automatically. Multi-channel pipettes can ...
... Yeast Whole Genome ChIP-on-chip Microarray is ... yeast (S. cerevisiae) DNA binding proteins ... Agilent DNA microarrays. This set delivers ... with greater true binding events and ...
... Yeast Whole Genome ChIP-on-chip Microarray is ... yeast (S. cerevisiae) DNA binding proteins ... Agilent DNA microarrays. This set delivers ... with greater true binding events and ...
... This kit is designed for easy ... The protocol allows for successful transformation simply ... kit reagents with cultured yeast cells. No ... washing, are required. The kit is particularly ...
Biology Products: